News|Articles|September 1, 2025
FDA Activity Recap: August 2025 Features Papillomatosis Gene Therapy Approval, Eli-Cel Labelling Update, and More
Author(s)Noah Stansfield
Catch up on any of the key FDA news stories you may have missed last month, with coverage highlights from the CGTLive® team.
Advertisement
Advertisement
Last month, August 2025, the CGTLive® team was diligently tracking the FDA's activities related to the development of cell and gene therapies for the treatment of rare, complex, and otherwise challenging diseases and disorders.
Advertisement
Advertisement